FOIU 2018: Should the Primary Be Treated in Patients with Metastatic Disease? - Testicular Cancer

Tel-Aviv, Israel (UroToday.com) Joel Sheinfeld, MD gave a short briefing discussing whether the primary tumor should be treated in metastatic testicular cancer patients. In short, the answer is Yes. Dr. Sheinfeld gave some data on delayed orchiectomy following chemotherapy. Teratoma is evident in 19-31% of cases, and a viable tumor is present in 13-30% of cases. Chemotherapy does not reliably treat germ cell tumors (GCT) in the testicle, nor does it treat germ cell neoplasia in situ (GCNIS), common in more than 90% of GCT patients. The morbidity in treating the primary tumor in testicular cancer is minimal and there is no contraindication to it.
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe